Form 4 holding
EVP Finance CFO
REGENERON PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 19,984
- Estimated value
- $12,460,823
- Report date
- 18 Aug 2026
- Price
- $623.54
- Ownership
- Direct
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|